Levenson Jeremy E MD is categorized under Ophthalmologists in Los Angeles, CA and active since 1973.
Levenson Jeremy E MD was established in 1973, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jeremy Levenson at the company’s single location by writing to 11645 Wilshire Boulevard # 600, Los Angeles, California CA 90025 or by phoning (310) 456-9880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Levenson Jeremy E MD |
Contact Person: | Jeremy Levenson |
Address: | 11645 Wilshire Boulevard # 600, Los Angeles, California 90025 |
Phone Number: | (310) 456-9880 |
Website Address: | pacificspecialists.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1973 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ophthalmologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Levenson Jeremy E MD was started in 1973 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jeremy Levenson for inquiries that concern Levenson Jeremy E MD by calling the company number (310) 456-9880, as your correspondence is most welcome. Additionally, the physical location of the single location of Levenson Jeremy E MD can be found at the coordinates 34.049878,-118.46024 as well as the street address 11645 Wilshire Boulevard # 600 in Los Angeles, California 90025.
For its online presence, you may visit Levenson Jeremy E MD’s website at pacificspecialists.com and engage with its social media outlets through on Twitter and on Facebook.